10-year survival rate of stage 3 nasopharyngeal carcinoma

Nasopharyngeal cancer is considered a life-threatening disease in daily life. Once you are diagnosed with nasopharyngeal cancer, there is almost no hope for your life. Treatment can only help prolong your life. However, you must not give up on the treatment of nasopharyngeal cancer. So how long can you live with nasopharyngeal cancer? Let's learn more about it!

For patients with advanced nasopharyngeal tumors, biological immunotherapy can effectively enhance the patient's immunity, improve the patient's quality of life, and maximize the patient's life. Biological immunotherapy achieves the purpose of treating tumors without destroying the body's immune system function. It mainly uses biotechnology to cultivate autologous immune cells that kill tumors in a standard laboratory, and then infuse them back into the body to directly kill cancer cells. Different from traditional treatment methods, biological immunotherapy mainly mobilizes the body's natural anti-cancer ability and restores the balance of the body's internal environment.

The survival period of patients with nasopharyngeal tumors is related to the patient's body function. Only with good body function and strong immunity can one resist the development of cancer and tolerate various drug treatments. Therefore, improving immune function and enhancing resistance to tumors is extremely important for patients with advanced nasopharyngeal tumors.

In terms of diet, during radiotherapy and chemotherapy, you should eat foods that are easily digestible and rich in nutrients such as protein, vitamins, amino acids, etc.; quit smoking and drinking, and avoid spicy and irritating foods; and do not eat overly dry or rough foods.

Warm reminder: The occurrence of nasopharyngeal cancer is quite unfortunate, but the incidence of nasopharyngeal cancer has been very high in recent years. For nasopharyngeal cancer, we must reflect on why more and more people are threatened by nasopharyngeal cancer? We must pay attention to nasopharyngeal cancer!